AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $686,120 | -9.4% | 27,722 | +3.7% | 0.00% | -20.0% |
| Q2 2023 | $757,164 | +25.1% | 26,736 | +1.5% | 0.01% | +25.0% |
| Q1 2023 | $605,030 | -16.5% | 26,340 | +2.0% | 0.00% | -20.0% |
| Q4 2022 | $724,885 | -1.1% | 25,815 | -0.4% | 0.01% | 0.0% |
| Q3 2022 | $733,000 | +29.5% | 25,909 | +1.4% | 0.01% | +25.0% |
| Q2 2022 | $566,000 | -27.9% | 25,544 | -5.3% | 0.00% | 0.0% |
| Q1 2022 | $785,000 | -17.3% | 26,978 | -6.6% | 0.00% | -20.0% |
| Q4 2021 | $949,000 | -36.3% | 28,876 | -10.6% | 0.01% | -37.5% |
| Q3 2021 | $1,490,000 | -21.7% | 32,283 | -6.5% | 0.01% | +33.3% |
| Q2 2021 | $1,902,000 | +4539.0% | 34,521 | +4236.8% | 0.01% | – |
| Q1 2021 | $41,000 | +7.9% | 796 | -8.3% | 0.00% | – |
| Q4 2020 | $38,000 | +22.6% | 868 | -1.0% | 0.00% | – |
| Q3 2020 | $31,000 | -34.0% | 877 | -1.1% | 0.00% | – |
| Q2 2020 | $47,000 | +30.6% | 887 | -13.0% | 0.00% | – |
| Q1 2020 | $36,000 | -12.2% | 1,019 | +19.6% | 0.00% | – |
| Q4 2019 | $41,000 | +41.4% | 852 | -3.3% | 0.00% | – |
| Q3 2019 | $29,000 | -34.1% | 881 | 0.0% | 0.00% | – |
| Q2 2019 | $44,000 | -43.6% | 881 | -24.1% | 0.00% | – |
| Q1 2019 | $78,000 | +41.8% | 1,161 | -3.4% | 0.00% | – |
| Q4 2018 | $55,000 | -40.9% | 1,202 | 0.0% | 0.00% | – |
| Q3 2018 | $93,000 | -7.9% | 1,202 | -0.2% | 0.00% | – |
| Q2 2018 | $101,000 | +9.8% | 1,204 | +7.5% | 0.00% | – |
| Q1 2018 | $92,000 | +64.3% | 1,120 | +15.0% | 0.00% | – |
| Q4 2017 | $56,000 | +9.8% | 974 | -2.4% | 0.00% | – |
| Q2 2017 | $51,000 | +24.4% | 998 | +41.8% | 0.00% | – |
| Q1 2017 | $41,000 | +46.4% | 704 | +4.9% | 0.00% | – |
| Q4 2016 | $28,000 | -99.9% | 671 | 0.0% | 0.00% | – |
| Q3 2016 | $35,442,000 | +20.9% | 671 | -4.1% | 0.00% | – |
| Q2 2016 | $29,327,000 | -24.8% | 700 | -26.2% | 0.00% | – |
| Q1 2016 | $39,000,000 | -36.1% | 948 | +1.6% | 0.00% | – |
| Q4 2015 | $61,000,000 | +77115.2% | 933 | -16.2% | 0.00% | – |
| Q3 2015 | $79,000 | -99.9% | 1,114 | +16.5% | 0.00% | – |
| Q2 2015 | $106,250,000 | -88.0% | 956 | -89.8% | 0.00% | -100.0% |
| Q1 2015 | $886,797,000 | -15.8% | 9,404 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $1,053,624,000 | +93.6% | 9,404 | +6.0% | 0.01% | +150.0% |
| Q3 2014 | $544,236,000 | +33.8% | 8,871 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $406,790,000 | +123.5% | 8,878 | +91.0% | 0.00% | +100.0% |
| Q1 2014 | $181,969,000 | +67.5% | 4,648 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $108,637,000 | – | 4,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |